BGE-175
Showing 1 - 25 of 116
Acute Posthemorrhagic Anemia Trial in Gosford (drug, dietary supplement, other)
Withdrawn
- Acute Posthemorrhagic Anemia
- BGE-117, 4mg
- +3 more
-
Gosford, New South Wales, AustraliaRenal Research
Apr 29, 2022
NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting
Not yet recruiting
- Non-small Cell Lung Cancer
- +5 more
- Autologous, engineered T Cells targeting TP53 R175H
-
Duarte, CaliforniaCity of Hope
May 17, 2023
Fasting, Perioperative Pulmonary Aspiration Trial in Hjørring (Ice water)
Completed
- Fasting
- Perioperative Pulmonary Aspiration
- Ice water
-
Hjørring, North Denmark, DenmarkDepartment of Anaestesia
Jan 5, 2023
Postpartum Trial in Batman (skin-to-skin contact)
Completed
- Postpartum
- skin-to-skin contact
-
Batman, TurkeyHatice OKÇU
Mar 26, 2023
Healthy Volunteers Bioavailability Study Trial in Xuzhou (Revefenacin Inhalation Solution)
Completed
- Healthy Volunteers Bioavailability Study
- Revefenacin Inhalation Solution
-
Xuzhou, ChinaXuzhou Central Hospital
Mar 21, 2022
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Cancer Trial in United States (IK-175 + nivolumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +5 more
- IK-175 + nivolumab
-
Chicago, Illinois
- +3 more
Jul 26, 2022
Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin
Recruiting
- Carcinoma, Ovarian Epithelial
- Low Grade Serous Adenocarcinoma of Ovary
- Letrozole tablets
- carboplatin AUC 5 and paclitaxel 175 mg/m2
-
Brescia, BS, Italy
- +1 more
Oct 26, 2022
COPD Trial in China (Revefenacin 175 mcg in 3 ML Inhalation Solution, Placebo inhalation solution QD)
Recruiting
- COPD
- Revefenacin 175 mcg in 3 ML Inhalation Solution
- Placebo inhalation solution QD
-
Beijing, Beijing, China
- +2 more
Feb 22, 2022
Chemo-induced Peripheral Neuropathy Trial in Goshen, Ogden (WST-057 Active, Placebo)
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- WST-057 Active
- Placebo
-
Goshen, Indiana
- +1 more
Aug 3, 2022
SHARE Project Define
Recruiting
- HIV
-
Tallahassee, FloridaFlorida State University, Center for Translational Behavioral Sc
Nov 6, 2023
Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)
Not yet recruiting
- Stage III Ovarian Cancer
- +5 more
- Cisplatin
- No treatment
- (no location specified)
Dec 12, 2022
Well-being Trial in Amsterdam (LifeHack, LifeHack-C)
Recruiting
- Well-being
- LifeHack
- LifeHack-C
-
Amsterdam, NetherlandsVrije Universiteit Amsterdam
Oct 24, 2022
Ovarian Cancer, Hyperthermic Intraperitoneal Chemo, Paclitaxel Trial in Guangzhou (Hyperthermic Intraperitoneal Paclitaxel
Recruiting
- Ovarian Cancer
- +2 more
- Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin
-
Guangzhou, Other (Non U.s.), ChinaSun Yat-sen Memorial Hospital
Nov 11, 2022
IBS - Irritable Bowel Syndrome, Diarrhea Trial in Shanghai, Chengdu (QiMeiYan Probiotics, Placebo product)
Not yet recruiting
- IBS - Irritable Bowel Syndrome
- Diarrhea
- QiMeiYan Probiotics
- Placebo product
-
Shanghai, Shanghai, China
- +1 more
Jun 2, 2023
Preoperative Insomnia and Postoperative Quality of Recovery : A
Recruiting
- Sleep Disorder
-
Guangzhou, Guangdong, Chinathe Sixth Affiliated Hospital, Sun Yat-sen University
Aug 21, 2023
Smoking, Alcoholism Trial in Newington (Cognitive Behavior Therapy for alcohol and smoking cessation, Nicoderm CQ nicotine
Completed
- Smoking
- Alcoholism
- Cognitive Behavior Therapy for alcohol and smoking cessation
- +3 more
-
Newington, ConnecticutVA Connecticut Healthcare System
Aug 11, 2021
Child Development Trial in Boston, Longacres (ECD intervention for CHEUs, Usual care for CHEUs)
Enrolling by invitation
- Child Development
- ECD intervention for CHEUs
- Usual care for CHEUs
-
Boston, Massachusetts
- +1 more
May 2, 2022
Recurrent/Advanced Gastric Cancer Trial in Seoul (Chemotherapy)
Not yet recruiting
- Recurrent/Advanced Gastric Cancer
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Aug 22, 2022
Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides
Active, not recruiting
- Bronchopulmonary Dysplasia; Retinopathy of Prematurity
- Integrated proteomic HPLC-ESI-MS analysis of salivary peptides
-
Roma, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 13, 2023
Uterine Cervical Tumors Trial in Worldwide (Nintedanib, Placebo)
Active, not recruiting
- Uterine Cervical Neoplasms
- Nintedanib
- Placebo
-
Bruxelles, Belgium
- +31 more
Mar 1, 2022
Umbilical Cord Infection, Umbilical Sepsis, Neonatal Sepsis Trial in Bedong (Adhesive pouch)
Recruiting
- Umbilical Cord Infection
- +2 more
- Adhesive pouch
-
Bedong, Kedah, MalaysiaAIMST University Malaysia
Oct 4, 2022